This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through February 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Zacks News
Should You Buy the Dip in Marijuana ETFs Ahead of Earnings?
by Sanghamitra Saha
Hexo's downbeat results weigh on marijuana space but many key pot companies are likely to beat in November. This could provide a good entry points to pot ETFs.
How to Invest in Emerging Industries Like Marijuana
by Tracey Ryniec
Investors are still crazy about the pot stocks despite this year's roller coaster ride.
Reefer Madness: Breaking Down The Current Cannabis Industry
by Panel Of Zacks Experts
Today we are joined by David Borun to discuss everything we need to know about the marijuana industry.
ETF Frenzy: Everything You Need To Know
by Panel Of Zacks Experts
Zacks' Resident ETF Expert, Neena Mishra, joins us to help teaches us about ETFs, ETNs and mutual funds
Top & Flop ETFs of Last Week
by Sweta Killa
Wall Street logged in the first weekly decline of a month. Inside the best and worst performing ETFs.
One More Marijuana ETF on the Block
by Sanghamitra Saha
As Global X launches a fresh pot ETF, let's explore the product in detail.
Buy Aurora Cannabis (ACB) Stock Before Earnings, Despite Marijuana Volatility?
by Benjamin Rains
Despite growing sales and wider legalization, many pot stocks have been insanely volatile as Wall Street and investors try to wrap their heads around the marijuana industry. So should you think about buying "cheap" Aurora Cannabis (ACB) Stock before Q4 earnings?
5 ETFs Surge With Wall Street on Trade Talk Hopes
by Sweta Killa
We have highlighted five ETFs that gained most with the Wall Street rebound on Sep 5.
Spooked About Recessionary Fears? Bet on Sin Stocks & ETFs
by Sanghamitra Saha
These sin stocks and ETFs may prove to be recession-proof.
ETF Winners & Losers of Last Week
by Sweta Killa
We have highlighted last week's best and worst performing ETFs.